To access this element change to forms mode OFF
Grant Award View - GA58872
Immunobiology of cancer and new cancer treatments
GA ID:
GA58872
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Aug-2019
Publish Date:
30-Sep-2019
Category:
Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2024
Value (AUD):
$1,701,595.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 19/20 1.1 Health and Medical Research
Grant Program:
Investigator
Grant Activity:
Immunobiology of cancer and new cancer treatments
Purpose:
Cytotoxic lymphocytes protect us from cancer and viruses by destroying ‘rogue’ cells that endanger the host. ‘Killer’ cells use two toxins, a pore-forming protein (perforin) and proteases (granzymes) to bring about cell death. I will decipher the molecular/cellular mechanisms underpinning this process, and use the information to devise new immune-based therapies for cancer, dangerous infections and excessive immune activity that results in auto-immune disorders such as lupus and type I diabetes.
GO ID:
GO Title:
Investigator Grants 2019
Internal Reference ID:
GNT1175470
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA